Clinical trial
Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
NCT07057596 is registered in ClinicalTrials.gov with Grupo Español Multidisciplinar de Melanoma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
- Lead sponsor
- Grupo Español Multidisciplinar de Melanoma
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 18, 2025
- Completion date
- December 31, 2027
- Enrollment
- 19 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
mestastatic uveal melanoma